ScholarLens Back to search
2023•Bone Marrow TransplantationOpen access

On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone

Anne Hubben, Danai Dima, Tahani Atieh, Chakra P. Chaulagain, Beth Faiman, Christina Ferraro, Sandra Mazzoni, Louis Williams, Christy Samaras, Jason Valent, Craig S. Sauter, Faiz Anwer, Jack Khouri

Open full text 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Plerixafor, Mobilization, Medicine, Progenitor cell, Amyloidosis, Haematopoiesis, Surgery, Oncology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone — Research Paper | ScholarLens